PELATIHAN DETEKSI DINI NEUROPATI AKIBAT KEMOTERAPI
DOI:
https://doi.org/10.29303/abdiinsani.v12i9.2843Keywords:
Detection, chemotherapy, neuropathyAbstract
Cancer is currently a disease that is experiencing significant growth. This has resulted in the number of chemotherapy administrations reaching 9.8 million to 15 million people and increasing by 53%. One of the side effects that can be caused is peripheral nerve disorders called Chemotherapy-Induced Peripheral Neuropathy (CIPN). In connection with the increasing number of cancer patients undergoing chemotherapy and the severe impact on peripheral nerves due to chemotherapy, early detection is very important to prevent severe complications. This training aims to improve the knowledge and skills of medical personnel in the early detection of chemotherapy-induced neuropathy in order to improve the quality of life of patients and reduce complications and disabilities due to neuropathy. This training was carried out in collaboration with the West Nusa Tenggara Province General Hospital and was attended by 62 nurses. The series of training activities included delivering materials and direct practice to patients. Evaluation of participant knowledge was through a pre-test using the Kahoot application and a post-test using the Plataran Sehat application with a pre-test completion time of 5 minutes. The average pre-test score was 59.35, while the average post-test score was 79.35. The simulation sessions are conducted directly with patients using a neuropathy screening questionnaire, accompanied by a physician. The presentation of the material and the simulation sessions are highly beneficial in neuropathy screening, allowing early detection of neuropathy symptoms and prompt treatment.
Downloads
References
Aninditha, T., & Wiratman W. (2017). Buku Ajar Neurologi. 2nd ed. Jakarta (ID): Penerbit Kedokteran
Indonesia. 1–782 p.
Colvin L. A. (2019). Chemotherapy-induced peripheral neuropathy: where are we now?. Pain, 160
Suppl 1(Suppl 1), S1–S10. https://doi.org/10.1097/j.pain.0000000000001540
Open access article under the CC–BY-SA license. Copy right © 2025, Huniafi et al., 4559
Dros, J., Wewerinke, A., Bindels, P. J., & van Weert, H. C. (2009). Accuracy of monofilament testing to
diagnose peripheral neuropathy: a systematic review. Annals of family medicine, 7(6), 555–558.
https://doi.org/10.1370/afm.1016
Haris, Julhana. (2022). Edukasi Penggunaan Monofilament Dalam Deteksi Dini Neuropati Sensori
Diabetes Mellitus Tipe 2 Pada Kader Di Tengah Pandemi Covid-19 Kelurahan Kolo Kota Bima.
Jurnal Kreativitas Pengabdian Kepada Masyarakat (PKM), p-issn: 2615-0921 E-Issn: 2622-6030 5
(1): 89-97 https://ejurnalmalahayati.ac.id/index.php/kreativitas/article/view/5346
Haroen, H., & Gimon, I. (2024). Hubungan Jenis dan Siklus Kemoterapi dengan Derajat Neuropati pada
Pasien Keganasan. Medical Scope Journal, 6(2), 164–171.
https://doi.org/10.35790/msj.v6i2.53140
Hu, L. Y., Mi, W. L., Wu, G. C., Wang, Y. Q., & Mao-Ying, Q. L. (2019). Prevention and Treatment for
Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms. Current
neuropharmacology, 17(2), 184–196. https://doi.org/10.2174/1570159X15666170915143217
Justitia, I., Dewi, P. K. K. ., Fauzi, Y. R., & Hunaifi, I. (2024). Chemotherapy-Induced Peripheral
Neuropathy: Pathophysiology, Diagnosis, and Treatment. AKSONA, 4(2), 98–106.
https://doi.org/10.20473/aksona.v4i2.52071
Katta, B., Vijayakumar, C., Dutta, S., Dubashi, B., & Nelamangala Ramakrishnaiah, V. P. (2023). The
Incidence and Severity of Patient-Reported Side Effects of Chemotherapy in Routine Clinical Care:
A Prospective Observational Study. Cureus, 15(4), e38301. https://doi.org/10.7759/cureus.38301
Rahman N, Sukumar J, Lustberg MB. (2025). Chronic chemotherapy-induced peripheral neuropathy:
living with neuropathy during and after cancer treatments. Ann Palliat Med, 14(2): 196-216. doi:
21037/apm-24-154
Rattanakrong, N., Thipprasopchock, S., Siriphorn, A., & Boonyong, S. (2022). Reliability and Validity of
the EORTC QLQ-CIPN20 (European Organization for Research and Treatment of Cancer Quality of
Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale) among Thai
Women with Breast Cancer Undergoing Taxane-Based Chemotherapy. Asian Pacific journal of
cancer prevention : APJCP, 23(5), 1547–1553. https://doi.org/10.31557/APJCP.2022.23.5.1547
Sanklapur, V., Shruthi, S., & Attar, N. (2020). Accuracy of Monofilament in the Assessment of Diabetic
Neuropathy. Asian Journal of Medicine and Health, 18(7), 9–15.
https://doi.org/10.9734/ajmah/2020/v18i730219
Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., Colvin, L.A., & Fallon,
M. (2014). Incidence, prevalence, and predictors of chemotherapy-induced peripheral
neuropathy: A systematic review and meta-analysis. Pain, 155(12), 2461–2470.
https://doi.org/10.1016/j.pain.2014.09.020
Staff, N. P., Grisold, A., Grisold, W., & Windebank, A. J. (2017). Chemotherapy-induced peripheral
neuropathy: A current review. Annals of neurology, 81(6), 772–781.
https://doi.org/10.1002/ana.24951
Tsai, C. H., Lin, Y. H., Li, Y. S., Ho, T. L., Hoai Thuong, L. H., & Liu, Y. H. (2021). Integrated Medicine for
Chemotherapy-Induced Peripheral Neuropathy. International Journal of Molecular
Sciences, 22(17), 9257. https://doi.org/10.3390/ijms22179257
Wilson, B. E., Jacob, S., Yap, M. L., Ferlay, J., Bray, F., & Barton, M. B. (2019). Estimates of global
chemotherapy demands and corresponding physician workforce requirements for 2018 and
: a population-based study. The Lancet Oncology, 20(6), 769–780.
https://doi.org/10.1016/S1470-2045(19)30163-9
World Health Organization. (2024). Global cancer burden growing, amidst mounting need for
service. Diakses pada 22 Desember 2024, dari https://www.who.int/news/item/01-02-2024-
global-cancer-burden-growing--amidst-mounting-need-for-services
